Cerberus-backed biotech firm files $894m IPO

This is the firm's third exit attempt for Talecris, which previously had a $3bn trade sale and $1bn IPO fall apart. If successful, it would be the largest US IPO in 2009.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this